Quantcast
Last updated on April 19, 2014 at 18:42 EDT

VetNostic Laboratories® Announces New Testing for Dog Breeds

October 27, 2011

HAMILTON, N.J., Oct. 27, 2011 /PRNewswire/ — VetNostic Laboratories® offers state-of-the-art genetic testing services for dog breeders and owners. Using DNA analysis, they are able to accurately and specifically determine whether or not a dog carries disease-causing genes. Providing reliable identification of these “carriers” ensures healthy litters and a successful breeding program. At this time, VetNostic Laboratories® is pleased to introduce two new tests to its growing diagnostic menu, Primary Lens Luxation and Greyhound Polyneuropathy.

Primary Lens Luxation (PLL) is a potentially blinding inherited disease in many Terrier breeds. It occurs when the ligaments holding the lens of the eye break down, causing it to dislocate. This can result in painful, teary, red eyes that may look hazy or cloudy. If not diagnosed and properly treated, PLL may lead to Uveitis and/or Glaucoma. This test is relevant to the following breeds: American Eskimo Dog, American Hairless (Rat) Terrier, Australian Cattle Dog, Chinese Crested, Chinese Foo Dog, Jack Russell Terrier, Jagd Terrier, Lakeland Terrier, Lancashire Heeler, Miniature Bull Terrier, Parson Russell Terrier, Rat Terrier, Russell Terrier, Sealyham Terrier, Teddy Roosevelt Terrier, Tenterfield Terrier, Tibetan Terrier, Toy Fox Terrier, Volpino Italiano, and Welsh Terrier.

Greyhound Polyneuropathy is a fatal neurological disease specific to the Greyhound show dog population. Symptoms include decreased or absent reflexes, muscle weakness, muscle pain and cramps, and a bunny-hopping gait. It usually appears within the first 9 months of age and then progresses so quickly that most affected dogs must be euthanized within their first year of life. Currently, there is no effective treatment for Greyhound Polyneuropathy.

VetNostic Laboratories® genetic tests for PLL and Greyhound Polyneuropathy can reliably identify dogs that are either clear, or possess one or two copies of the disease-causing genes which they may pass to their offspring. This clear, carrier, or affected result can help breeders determine which animals to include in their breeding programs.

Dr. Martin E. Adelson, Vice President of the Genesis Biotechology Group, stated, “We are pleased to continually add to the diversity of testing services offered by VetNostic Laboratories®. These most recent tests will help breeders to eliminate diseases such as PLL and Greyhound Polyneuropathy from future generations. This testing also provides true value to breeders as they can authenticate that their puppies are clear of common disorders caused by genetic mutations. It’s an exciting time in the field of canine molecular diagnostics.”

VetNostic Laboratories®, a division of Medical Diagnostic Laboratories, L.L.C., is a company within the Genesis Biotechnology Group. They are located in “Einstein’s Alley,” the research and technology corridor in Hamilton, New Jersey. Their facility is easily accessible in the New York, New Jersey, and Pennsylvania area.

VetNostic Laboratories® offers a web-based shopping cart to make molecular diagnostic testing readily available to the dog breeder and owner communities. Through this online ordering system, they are able to view test descriptions and order specimen collections kits. Specimen collection instructions and a “How-To” video facilitate step-by-step collection of cheek swabs from dogs.

To find out more, please visit http://www.vetnostic.com

Contact:

Rob Mason
Research Scientist
rmason@vetnostic.com
877.255.9208
http://www.vetnostic.com

This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE VetNostic Laboratories


Source: PR Newswire